LifeStance Health Group, Inc. (LFST)
USD 7.09
(-5.21%)
USD 7.09
(-5.21%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 302.09 Million USD | -6.48% |
| 2022 | 237.01 Million USD | 17.62% |
| 2021 | 201.5 Million USD | 50.02% |
| 2020 | 134.32 Million USD | 115.27% |
| 2019 | 62.39 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 72.16 Million USD | 18.11% |
| 2024 Q2 | 79.2 Million USD | 9.76% |
| 2023 Q1 | 69.6 Million USD | 11.02% |
| 2023 FY | 221.65 Million USD | -6.48% |
| 2023 Q4 | 61.09 Million USD | -19.83% |
| 2023 Q3 | 76.2 Million USD | 4.44% |
| 2023 Q2 | 72.97 Million USD | 4.84% |
| 2022 Q3 | 60.29 Million USD | 0.77% |
| 2022 Q2 | 59.83 Million USD | 10.38% |
| 2022 Q1 | 54.2 Million USD | -0.09% |
| 2022 FY | 237.01 Million USD | 17.62% |
| 2022 Q4 | 62.69 Million USD | 3.98% |
| 2021 Q1 | 43.99 Million USD | 12.88% |
| 2021 FY | 201.5 Million USD | 50.02% |
| 2021 Q4 | 54.25 Million USD | 4.22% |
| 2021 Q3 | 52.05 Million USD | 1.65% |
| 2021 Q2 | 51.2 Million USD | 16.39% |
| 2020 Q3 | 33.13 Million USD | 133.71% |
| 2020 Q2 | 14.17 Million USD | -33.97% |
| 2020 Q1 | 21.47 Million USD | 0.0% |
| 2020 FY | 134.32 Million USD | 115.27% |
| 2020 Q4 | 38.97 Million USD | 17.64% |
| 2019 FY | 62.39 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 682.6 Million USD | 55.744% |
| Addus HomeCare Corporation | 339.87 Million USD | 11.116% |
| AirSculpt Technologies, Inc. | 121.9 Million USD | -147.813% |
| Amedisys, Inc. | 457.07 Million USD | 33.907% |
| American Oncology Network, Inc. | 66.05 Million USD | -357.326% |
| Astrana Health, Inc. | 214.95 Million USD | -40.537% |
| Aveanna Healthcare Holdings Inc. | 595.43 Million USD | 49.264% |
| IMAC Holdings, Inc. | 3.84 Million USD | -7749.467% |
| biote Corp. | 127.48 Million USD | -136.97% |
| Cryo-Cell International, Inc. | 22.9 Million USD | -1219.117% |
| Cross Country Healthcare, Inc. | 432.06 Million USD | 30.081% |
| COMPASS Pathways plc | -242.93 Thousand USD | 124451.069% |
| DocGo Inc. | 178.95 Million USD | -68.815% |
| The Ensign Group, Inc. | 590.75 Million USD | 48.863% |
| Healthcare Services Group, Inc. | 251.45 Million USD | -20.142% |
| InnovAge Holding Corp. | 132.06 Million USD | -128.75% |
| Assure Holdings Corp. | -2.19 Million USD | 13869.189% |
| The Joint Corp. | 107.14 Million USD | -181.938% |
| Mobile-health Network Solutions Class A Ordinary Shares | -1.07 Million USD | 28289.932% |
| ModivCare Inc. | 446.95 Million USD | 32.41% |
| NewGenIvf Group Limited | 1.68 Million USD | -17862.819% |
| Novo Integrated Sciences, Inc. | 4.95 Million USD | -5999.604% |
| Option Care Health, Inc. | 981.22 Million USD | 69.212% |
| P3 Health Partners Inc. | 31.63 Million USD | -854.942% |
| P3 Health Partners Inc. | 31.63 Million USD | -854.942% |
| The Pennant Group, Inc. | 61.9 Million USD | -387.991% |
| Surgery Partners, Inc. | 529.4 Million USD | 42.936% |
| Syra Health Corp. Class A Common Stock | 1.41 Million USD | -21296.416% |
| Talkspace, Inc. | 74.38 Million USD | -306.152% |
| Talkspace, Inc. | 74.38 Million USD | -306.152% |
| The Oncology Institute, Inc. | 59.57 Million USD | -407.102% |
| The Oncology Institute, Inc. | 59.57 Million USD | -407.102% |